Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
116
days
Early and late CTCAE and patient-reported outcomes following lung cancer radiotherapy: A sex-stratified descriptive analysis from the REQUITE cohort
Authors
Miguel E. Aguado-Barrera; Patricia Calvo-Crespo; Begoña Taboada-Valladares; Antonio Gomez-Caamaño; Angel Carracedo; David Azria; Erik Briers; Jenny Chang-Claude; Dirk de Ruysscher; Gilles Defraene; Rebecca M. Elliott; Corinne Faivre-Finn; Marzia Franceschini; Olivia Fuentes-Rios; Alexandra Giraldo; Tommaso Giandini; Sara Gutiérrez-Enríquez; Philipp Heumann; Daniel S. Higginson; Kerstie Johnson; Maarten Lambrecht; Yolande Lievens; Meritxell Mollà; Tiziana Rancati; Tim Rattay; Mónica Ramos; Barry S. Rosenstein; Petra Seibold; Elena Sperk; Hilary Stobart; Paul Symonds; Christopher J. Talbot; Katrien Vandecasteele; Liv Veldeman; Tim Ward; Adam Webb; Catharine M.L. West; Vega AnaShow moreShow less
Affiliations
Grupo Genética en Cáncer y Enfermedades Raras, Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain; Department of Radiation Oncology, Hospital Clínico Universitario de Santiago de Compostela, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain; Genomic Medicine Group, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; Biomedical Network on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; Genetics Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain; Fédération Universitaire d'oncologie radiothérapie d'Occitanie Méditerranée, ICM, INSERM U1194 IRCM, Univ Montpellier, Montpellier, France; Patient Advocat, Hasselt, Belgium; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Cancer Epidemiology Group, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Maastricht University Medical Center, Department of Radiation Oncology (Maastro clinic), GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands; Department of Oncology, KU Leuven, Leuven, Belgium; Translational Radiobiology Group, Division of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, United Kingdom; Clinical Oncology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom; Radiation Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Radiation Oncology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medical Physics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom; Department of Radiation Oncology, UZ Gasthuisberg Leuven, Leuven, Belgium; Radiation Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium; Unit of Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Radiation Oncology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Independent Cancer Patients' Voice, United Kingdom; Division of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom; Trustee Pelvic Radiation Disease Association, NCRI CTRad Consumer, United KingdomShow moreShow less
70
days
Post-SABR early PSA density kinetics in androgen deprivation therapy-naïve patients: early landmark models for long-term biochemical recurrence-free survival
Authors
Carlo Greco; Bruno Vieira; Oriol Pares; Nuno Pimentel; Vasco Louro; Beatriz Nunes; Justyna Kociolek; Miguel Simas; Zvi FuksShow moreShow less
Affiliations
Champalimaud Centre for the Unknown, Lisbon, PortugalShow moreShow less
73
days
European lung cancer congress 2026 – the thoracic radiation oncologist's view.
Authors
Franz Zehentmayr; Andreas Rimner; Denise Bernhardt; Lukas Käsmann; Eleni Gkika; Rami El-Shafie; Christoph Pöttgen; Martin Stuschke; Maja Guberina; Nika GuberinaShow moreShow less
Affiliations
Dept. of Radiation Oncology, Paracelsus Medical University, Salzburg, Austria; Dept. of Radiation Oncology, Comprehensive Cancer Centre Freiburg, Freiburg, Germany; Dept. of Radiation Oncology, Technical University Munich, Munich, Germany; Dept. of Radiation Oncology, Klinikum Landshut, Landshut, Germany; Dept. of Radiation Oncology, Universitätsklinikum Bonn, Germany; Dept. of Radiation Oncology, Göttingen University Medical Centre, Göttingen, Germany; Dept. of Radiation Oncology, University of Duisburg-Essen, Essen, GermanyShow moreShow less
79
days
Recurrence distance analysis for clinical target volume optimization in glioblastoma
Authors
Patrick L.Y. Tang; Marion Smits; Erik D. van Werkhoven; Remi A. Nout; Esther A.H. Warnert; Alejandra Méndez RomeroShow moreShow less
Affiliations
Brain Tumor Center, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands; Medical Delta, Delft, NetherlandsShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days